ArticlePolymers2024
New Composite Materials Based on PVA, PVP, CS, and PDA.
Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Freeze-Dried CS/PVP/PVA Composite Scaffolds Doped with Curcumin and SiOInternational journal of molecular sciences · 2026Article
- Dissolving Microneedles with Smart Design-A Tool for Enhancing Skin Permeation of Naltrexone Hydrochloride.Molecules (Basel, Switzerland) · 2026Article
- Recent advances in polymer-based drug delivery systems for atopic dermatitis: enhancing therapeutic efficacy and outcomes.Materials today. Bio · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, new materials based on the blends of polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP), chitosan (CS), and polydopamine (PDA) have been prepared. Fourier Transform Infrared Spectra have been conducted to verify the presence of individual components in the composite materials. EDX elemental analysis showed a clear view of the element's presence in the composite materials, with the maximum values for carbon and oxygen. Atomic force microscopy (AFM) was used to observe the surface topography and measure the surface roughness. In the case of the individual polymers, CS presented the higher value of surface roughness (Rq = 3.92 nm and Ra = 3.02 nm), and surface roughness was found to be the lowest in the case of polyvinyl pyrrolidone (PVP), and it was with values (Rq = 2.34 nm and Ra = 0.95 nm). PVA films presented the surface roughness, which was with the value (Rq = 3.38 nm and Ra = 2.11 nm). In the case of composites, surface roughness was highest for the composite based on PVA, PVP, and CS, which presented the value (Rq = 11.91 nm and Ra = 8.71 nm). After the addition of polydopamine to the polymeric composite of PVA, PVP, and CS, a reduction in the surface roughness was observed (Rq = 7.49 nm and Ra = 5.15 nm). The surface roughness for composite materials was higher than that of the individual polymers. The addition of PDA to polymeric composite (PVA/PVP/CS) led to a decrease in Young's modulus. The elongation percentage of the polymeric films based on the PVA/PVP/CS/PDA blend was higher than that of the blend without PDA (9.80% vs. 5.68% for the polymeric composite PVA/PVP/CS). The surface of polymeric films was hydrophilic. The results from the MTT assay showed that all tested specimens are non-toxic, and it was manifested by a significant increase in the viability of L929 cells compared with control cells. However, additional studies are required to check the biocompatibility of tested samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.